Skip to main content
OpenTrials

Clinical trial condition

Age-Related Macular Degeneration

Explore clinical trials studying Age-Related Macular Degeneration. Study availability and eligibility vary by location and protocol.

288 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Age-Related Macular Degeneration trial results

Active, not recruiting

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

NCT05230537

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +10 more
Locations
  • Retina Consultants of Orange County Fullerton, California, United States
  • Salehi Retina Institute Huntington Beach, California, United States
  • Martel Eye Medical Group Rancho Cordova, California, United States
  • Retinal Consultants Medical Group Inc Sacramento, California, United States
View all 28 locations
View Trial Details
Active, not recruiting

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

NCT05300724

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Retina Partners of Northwest Arkansas, PLLC Springdale, Arkansas, United States
  • The Retina Partners Encino, California, United States
  • Retina Consultants of Orange County Fullerton, California, United States
  • Northern California Retina Vitreous Associates Mountain View, California, United States
View all 74 locations
View Trial Details
Active, not recruiting

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

NCT06970665

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +3 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Kagawa University Hospital Kita-gun, Kagawa-ken, Japan
  • Yokohama City University Medical Center Yokohama, Kanagawa, Japan
View all 16 locations
View Trial Details
Active, not recruiting

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

NCT05984927

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +11 more
Locations
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Vancouver Coastal Health Research Institute Vancouver, British Columbia, Canada
  • Sunnybrook Ophthalmology and Vision Services Toronto, Ontario, Canada
  • Vitreous Retina Macula Specialists of Toronto Toronto, Ontario, Canada
View Trial Details
Active, not recruiting

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

NCT06087458

Conditions
Age-Related Macular Degeneration, Eye Diseases, Geographic Atrophy, +5 more
Locations
  • Retina Macula Institute of AZ Scottsdale, Arizona, United States
  • Retinal Consultants Medical Group Sacramento, California, United States
  • Retina Center of Texas Southlake, Texas, United States
  • University of Utah John A. Moran Eye Center Salt Lake City, Utah, United States
View all 16 locations
View Trial Details
Active, not recruiting

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

NCT02286089

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • West Coast Retina Medical Group San Francisco, California, United States
  • Cincinnati Eye Institute Cincinnati, Ohio, United States
  • Mid Atlantic Retina Philadelphia, Pennsylvania, United States
  • Hadassah Medical Center Jerusalem, Israel
View Trial Details
Active, not recruiting

A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

NCT06825858

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Kanghong Investigative Site Phoenix, Arizona, United States
  • Kanghong Investigative Site Lemont, Illinois, United States
  • Kanghong Investigative Site Memphis, Tennessee, United States
View Trial Details

Related conditions